silence7@slrpnk.net to World News@lemmy.worldEnglish · 5 days agoGame-Changing HIV Shot Can’t Get to High-Risk Groups Fast Enough | Lenacapavir proved it's possible to prevent 100% of infections in women. Access and affordability are the next big hurdles.www.bloomberg.comexternal-linkmessage-square4fedilinkarrow-up1154arrow-down10
arrow-up1154arrow-down1external-linkGame-Changing HIV Shot Can’t Get to High-Risk Groups Fast Enough | Lenacapavir proved it's possible to prevent 100% of infections in women. Access and affordability are the next big hurdles.www.bloomberg.comsilence7@slrpnk.net to World News@lemmy.worldEnglish · 5 days agomessage-square4fedilink
minus-squarepartial_accumen@lemmy.worldlinkfedilinkEnglisharrow-up12·5 days ago“lenacapavir, a twice-yearly shot developed by Gilead Sciences for the prevention of HIV.” So its not a vaccine, but it would still be incredibly helpful in reducing the spread of of HIV.
“lenacapavir, a twice-yearly shot developed by Gilead Sciences for the prevention of HIV.”
So its not a vaccine, but it would still be incredibly helpful in reducing the spread of of HIV.